Female Reproductive & Breast

Pelvic organ prolapse: evaluation and management

Clinical Overview and When to Suspect Pelvic Organ Prolapse

— Lifetime risk of surgery for POP or incontinence ~13% in US women

— Prevalence rises sharply after menopause; ~40% of parous women >50 have some descent on exam

— Only a fraction are symptomatic — anatomic prolapse ≠ clinical disease

— Vaginal parity (especially operative vaginal delivery, macrosomia, prolonged second stage)

— Aging and estrogen deficiency (menopause)

— Obesity (BMI >30)

— Chronic increases in intra-abdominal pressure: chronic cough (COPD, smoking), constipation with straining, heavy occupational lifting

— Connective tissue disorders (Ehlers-Danlos, Marfan)

— Prior pelvic surgery, especially hysterectomy (vault prolapse)

— Family history; White and Hispanic women > Black and Asian women

Board pearl: The single strongest modifiable predictor on exam questions is vaginal parity; cesarean delivery substantially reduces but does not eliminate risk. Treat symptoms, not the POP-Q stage — asymptomatic stage II prolapse needs reassurance, not surgery.

Definition: Pelvic organ prolapse (POP) is descent of one or more pelvic structures — anterior vaginal wall (cystocele), posterior vaginal wall (rectocele/enterocele), uterus/cervix, or vaginal apex (post-hysterectomy vault) — into or beyond the vaginal canal due to pelvic floor support failure.

Epidemiology:

Core risk factors (high-yield):

When to suspect on Step 3: A multiparous, postmenopausal woman presents with a "bulge" or "something falling out" sensation, pelvic pressure worse at end of day or with standing/straining, with relief when supine. May coexist with stress incontinence, voiding dysfunction, splinting to defecate, or sexual dysfunction.

Outpatient framing: POP is almost always an ambulatory diagnosis; urgent presentation is rare except for procidentia with ulceration, urinary retention, or obstructive uropathy.

Presentation Patterns and Key History

— Worse with standing, lifting, end of day, prolonged activity

— Relieved by lying down or by manually reducing the bulge

— Anterior (cystocele): urinary urgency/frequency, incomplete emptying, slow stream, recurrent UTIs, need to splint anteriorly to void, paradoxical improvement of stress incontinence with severe prolapse (kinking of urethra)

— Posterior (rectocele): constipation, incomplete defecation, digital splinting of posterior vagina or perineum to evacuate stool, fecal urgency

— Apical (uterine/vault): deep pelvic pressure, low back ache improved by recumbency, dyspareunia, protrusion of cervix or vaginal cuff

— Enterocele: small bowel descent — often coexists with apical defects

— Obstetric: parity, birth weights, operative deliveries, perineal tears

— Surgical: hysterectomy, prior prolapse/incontinence repair, mesh use

— Bowel/bladder: incontinence (stress vs urge vs mixed), retention, constipation

— Lifestyle: occupational lifting, chronic cough, smoking

— Goals of care: sexually active? desires uterine preservation? surgical candidate?

Key distinction: Symptoms that worsen with upright posture and improve when supine strongly suggest POP; constant pelvic pain unrelated to position should redirect you toward endometriosis, interstitial cystitis, or musculoskeletal pelvic pain — POP rarely causes true pain.

Step 3 management: Always elicit patient treatment goals before choosing therapy — a woman who only wants to resume yoga is a pessary candidate; one with completed childbearing wanting definitive cure leans surgical.

Cardinal symptom: Sensation of a vaginal bulge, pressure, or heaviness — often the only symptom that correlates reliably with prolapse stage. Ask: "Do you see or feel a bulge from your vagina?"

Compartment-specific symptoms:

Sexual function history: dyspareunia, decreased sensation, avoidance, body image distress — ask specifically; patients underreport.

Quality-of-life screening tools (Step 3 favorites): PFDI-20 (Pelvic Floor Distress Inventory), PFIQ-7 — used to track symptom burden and treatment response, not to diagnose.

Targeted history checklist:

Physical Exam Findings and POP-Q Staging

— Empty bladder first; examine in dorsal lithotomy, then standing if exam underestimates symptoms

— Use a split (disassembled) Sims speculum — retract one wall at a time to isolate compartments

— Have patient Valsalva and cough to elicit maximum descent

— Anterior wall (bladder/urethra) with posterior blade retracting posteriorly

— Posterior wall (rectum) with anterior blade retracting anteriorly

— Apex (cervix or vaginal cuff) — pull gently with ring forceps if needed

— Perineal body integrity, genital hiatus, levator ani tone (squeeze strength 0–5 Oxford)

— Reference point: hymen = 0; above hymen = negative, beyond = positive (cm)

— Six points measured (Aa, Ba anterior; C, D apical; Ap, Bp posterior) plus genital hiatus, perineal body, total vaginal length

— Stages:

– Stage 0: no prolapse

– Stage I: leading edge >1 cm above hymen

– Stage II: within 1 cm of hymen (±1)

– Stage III: >1 cm beyond hymen but not full eversion

– Stage IV: complete eversion (procidentia)

— Cough stress test with prolapse reduced — unmasks occult stress urinary incontinence (critical preop)

— Postvoid residual (PVR) — bladder scan; >150 mL suggests outlet obstruction from prolapse

— Rectovaginal exam to assess enterocele and rectocele depth

— Inspect for ulceration, erosion, or bleeding of exposed mucosa in procidentia

— Neurologic: perineal sensation (S2–S4), anal wink, bulbocavernosus reflex if neurogenic suspected

Board pearl: A clinically important threshold is descent to or beyond the hymen (stage ≥II) — this is where symptoms typically begin and treatment becomes warranted.

Exam setup:

Compartments to assess:

POP-Q (Pelvic Organ Prolapse Quantification) — the standard:

Additional exam elements:

Hemodynamic note: POP itself is not a hemodynamic emergency, but procidentia with obstructive uropathy can cause AKI — check creatinine and bladder scan in advanced cases.

Diagnostic Workup — Initial Labs, Imaging, and Office Studies

— Urinalysis with reflex culture — rule out UTI in any woman with urinary symptoms or recurrent infections; treat before urodynamics

— Postvoid residual (PVR) via bladder scan or catheterization

– Normal <100 mL; >150 mL concerning; >300 mL = significant retention, evaluate for outlet obstruction

— Basic metabolic panel/creatinine if advanced prolapse (stage III–IV), suspected hydronephrosis, or chronic retention

— Hemoglobin if vaginal bleeding from erosion/ulceration

— Renal ultrasound for stage III–IV prolapse to evaluate hydronephrosis from ureteral kinking (especially procidentia)

— Pelvic ultrasound only if a coexisting pelvic mass is suspected on exam

— Dynamic MRI defecography reserved for complex multicompartment defects, suspected enterocele, prior failed repair, or defecatory dysfunction unexplained by exam

Step 3 management: Before any prolapse repair, you owe the patient three things — urinalysis, PVR, and a cough stress test with reduction — because they change operative planning. Skipping the reduction stress test is a classic exam pitfall leading to "new" postoperative incontinence.

POP is a clinical diagnosis — exam alone establishes it. Labs and imaging are adjuncts targeted to complications and to plan therapy.

Baseline office testing:

Cough stress test: Performed with comfortably full bladder, prolapse reduced with split speculum or pessary — observe for urine leakage with cough → identifies stress incontinence that will be unmasked after prolapse repair (occult SUI).

Voiding diary (3-day): quantifies frequency, nocturia, leakage episodes, fluid intake — helpful when LUTS coexist.

Imaging is NOT routine. Indications:

Cervical cancer screening: Ensure age-appropriate Pap/HPV is up to date — visible cervix in procidentia is the moment to catch a missed screen.

Endometrial sampling: Any postmenopausal bleeding or abnormal uterine bleeding before considering uterine-sparing surgery → biopsy first.

Diagnostic Workup — Advanced and Confirmatory Studies

— Not required for uncomplicated POP, but indicated when:

– Mixed urinary incontinence with unclear dominant component

– Elevated PVR or suspected voiding dysfunction

– Prior anti-incontinence surgery with recurrent symptoms

– Neurogenic bladder (MS, spinal cord disease, diabetes with autonomic neuropathy)

— Multichannel UDS measures detrusor pressure, flow, urethral function (Valsalva leak point pressure), and confirms detrusor overactivity vs stress mechanism

— Should be performed with prolapse reduced to detect occult SUI

— Indicated for hematuria, recurrent UTI, suspected fistula, or planning concomitant anti-incontinence procedure

— Routine intraoperative cystoscopy after prolapse/sling surgery to confirm ureteral efflux and bladder integrity

— Best for multicompartment defects, recurrent prolapse, enterocele vs rectocele discrimination, and rectal intussusception

— Visualizes peritoneocele and helps surgical planning for combined urogynecology/colorectal cases

— Smoking cessation (impairs mesh integration and wound healing)

— Glycemic control (HbA1c)

— Treat chronic cough and constipation

— Estrogen therapy (vaginal) for atrophic tissue 4–6 weeks preoperatively to improve tissue quality

Board pearl: "Occult stress incontinence" is the high-yield concept — up to 40% of women with advanced POP develop de novo SUI after repair if the urethra is unkinked. Always assess with the reduction stress test or UDS with pessary in place.

Urodynamic studies (UDS):

Cystoscopy:

Dynamic/defecography MRI:

Anorectal manometry and endoanal ultrasound: when fecal incontinence coexists or for sphincter assessment before posterior repair.

Translabial/perineal ultrasound: increasingly used by urogynecologists to evaluate levator ani avulsion and mesh position — not yet a board staple but appearing in vignettes about mesh complications.

Endometrial evaluation: Transvaginal ultrasound (endometrial stripe) plus biopsy for any postmenopausal bleeding before hysteropexy or hysterectomy.

Preoperative medical optimization:

Risk Stratification and First-Line Management Logic

— Is the patient symptomatic?

— What are her goals (sexual activity, surgery avoidance, definitive cure)?

— Is she a surgical candidate (comorbidities, life expectancy, anesthesia risk)?

— Observation is appropriate — reassure, lifestyle counseling, annual exam

— No evidence that early intervention prevents progression

— Exception: stage IV procidentia with hydronephrosis or ulceration requires treatment regardless of symptom burden

— Step 1: Conservative/lifestyle

– Weight loss (BMI reduction by 5–10% improves symptoms)

– Treat constipation (fiber, hydration, osmotic laxatives)

– Smoking cessation, cough control

– Avoid heavy lifting

— Step 2: Pelvic floor muscle training (PFMT)

– First-line for mild-to-moderate (stage I–II) prolapse

– Supervised PT with biofeedback superior to home Kegels alone

– 12–16 weeks before reassessment

– Best evidence for symptom improvement, modest anatomic effect

— Step 3: Pessary

– Appropriate for any stage, any age, including pregnancy

– Especially first-line if: poor surgical candidate, future childbearing desired, prefers nonsurgical option, awaiting surgery

— Step 4: Surgery — for refractory symptoms or patient preference

— Elderly with multiple comorbidities → pessary or obliterative procedure (colpocleisis)

— Young, sexually active, completed childbearing → reconstructive surgery (sacrocolpopexy or native tissue repair)

— Desires future pregnancy → conservative management until childbearing complete

Step 3 management: Offer all three tiers (lifestyle/PFMT, pessary, surgery) at the initial visit — this is a shared decision-making vignette favorite. Documenting that the patient declined the conservative option before pursuing surgery is both clinically and medicolegally appropriate.

Treatment algorithm hinges on three questions:

Asymptomatic prolapse (any stage):

Symptomatic prolapse — stepwise approach:

Patient selection nuances:

Pharmacotherapy — Vaginal Estrogen and Adjunctive Medications

— Forms: estradiol cream (1 g 2–3×/week), estradiol tablet 10 mcg (2×/week after 2-week loading), estradiol ring (every 90 days)

— Indications in POP:

– Postmenopausal atrophic vaginitis with prolapse-related erosion or pessary use

– Preoperative tissue optimization (4–6 weeks before repair)

– Pessary-related ulceration, discharge, or discomfort

– Recurrent UTIs in postmenopausal women

— Systemic absorption is minimal with low-dose vaginal preparations — no progestin needed for endometrial protection at standard low doses

— Contraindications: undiagnosed vaginal bleeding, active/recent estrogen-sensitive cancer (relative — discuss with oncology for breast cancer survivors; ospemifene or vaginal DHEA are alternatives)

— Vaginal DHEA (prasterone) 6.5 mg nightly — for dyspareunia/GSM, breast cancer–safe profile under discussion

— Ospemifene 60 mg PO daily — SERM for moderate-to-severe dyspareunia; avoid in VTE history

— Non-hormonal vaginal moisturizers and lubricants

— Overactive bladder symptoms: behavioral therapy first; then antimuscarinics (oxybutynin, tolterodine, solifenacin) — caution in elderly per Beers criteria (cognitive impairment, falls); β3-agonist mirabegron preferred in older adults

— Stress urinary incontinence: no FDA-approved oral therapy in US; duloxetine used off-label and outside US

— Fiber (psyllium 25–30 g/day), adequate hydration, PEG 3350 for chronic constipation worsening prolapse symptoms

Board pearl: Low-dose vaginal estrogen does not require concurrent progestin and is considered safe long-term in most women; this is a frequently tested point against the dated assumption that all estrogen needs progestin opposition.

There is no oral pharmacologic cure for POP. Drug therapy targets associated symptoms and tissue quality.

Vaginal estrogen (cornerstone adjunct):

Alternatives to vaginal estrogen:

Treating coexisting urinary symptoms:

Bowel symptom adjuncts:

Procedures — Pessaries and Surgical Management

— Support pessaries: ring (with or without support) — first choice, can remain in during intercourse

— Space-filling pessaries: Gellhorn, donut, cube — for advanced prolapse; must be removed for intercourse

— Fit by trial: largest size patient can comfortably wear, can sit/stand/void without expulsion

— Care: self-removal and cleaning weekly OR clinician removal every 3 months; concurrent vaginal estrogen reduces erosion

— Complications: discharge, odor, ulceration, rare fistula or incarceration if neglected

— Apical support (the keystone): strongest predictor of durable repair

– Sacrocolpopexy (abdominal/laparoscopic/robotic) — mesh from vaginal apex to anterior sacral ligament; gold standard for durability, especially in younger active women; ~90% success

– Uterosacral ligament suspension or sacrospinous ligament fixation — native tissue, transvaginal; lower mesh risk; higher recurrence than sacrocolpopexy

— Anterior repair (cystocele): anterior colporrhaphy (native tissue); transvaginal mesh largely withdrawn from US market (FDA 2019)

— Posterior repair (rectocele): posterior colporrhaphy ± perineorrhaphy

— Hysteropexy: uterine-sparing apical suspension for women desiring uterine preservation

— Obliterative procedures:

– Colpocleisis (LeFort if uterus present, total if post-hysterectomy) — sews vagina closed

– Indication: elderly, no desire for vaginal intercourse, high surgical risk

– Quick, low morbidity, ~95% success, highest satisfaction rates of any POP surgery

— Concomitant anti-incontinence procedure (midurethral sling) if SUI or occult SUI demonstrated

CCS pearl: For an 82-year-old with procidentia, hydronephrosis, multiple comorbidities, and no sexual activity → order renal US, basic labs, urology/urogynecology consult, and plan colpocleisis — not sacrocolpopexy. Match invasiveness to physiologic reserve and goals.

Pessary fitting (office procedure):

Surgical options — match procedure to anatomy and goals:

Special Populations — Elderly and Renal/Hepatic Impairment

— Prevalence and severity rise with age; most symptomatic POP patients are postmenopausal

— Frailty assessment drives decisions: gait speed, grip strength, Clinical Frailty Scale, comprehensive geriatric assessment for major surgical candidates

— Prefer less invasive options:

– Pessary as durable long-term solution — many women use a pessary for >10 years

– Colpocleisis when reconstruction is not desired — short OR time, regional anesthesia possible, fast recovery

— Avoid Beers-listed medications:

– Oxybutynin and other anticholinergics → confusion, falls, urinary retention

– Mirabegron preferred for OAB; monitor BP

— Vaginal estrogen is safe and improves pessary tolerance, urinary symptoms, and surgical tissue quality

— Address polypharmacy and fall risk — postoperative delirium prevention with HELP protocol elements

— Advanced POP (stage IV/procidentia) can cause bilateral ureteral kinking → obstructive uropathy and AKI

– Order renal ultrasound; reduction with pessary often resolves hydronephrosis within days to weeks

– Persistent obstruction warrants definitive surgical correction

— Drug dosing: oxybutynin and solifenacin require dose reduction in CrCl <30; mirabegron avoid in severe renal impairment

— Perioperative: hold ACEi/ARB and SGLT2 inhibitors per protocol; ensure euvolemia

— Limited direct relevance to POP, but consider:

– Ascites worsens intra-abdominal pressure and accelerates prolapse — control ascites first

– Coagulopathy from cirrhosis affects surgical candidacy

– Avoid hepatically metabolized antimuscarinics in severe liver disease

Board pearl: Stage IV procidentia + rising creatinine = imaging for hydronephrosis and prompt prolapse reduction (pessary or surgery). Missing obstructive AKI in a prolapse vignette is a classic Step 3 trap.

Elderly women (the dominant POP demographic):

Renal impairment:

Hepatic impairment:

Special Populations — Pregnancy, Postpartum, and Younger Women

— Rare but documented — typically presents in the second trimester as uterine prolapse worsens with growing uterus, then often improves as the uterus enters the abdomen

— Risks: cervical ulceration, urinary retention, preterm labor, ascending infection

— Management:

– Pessary is first-line — can be safely placed and worn throughout pregnancy

– Pelvic rest, bed rest in severe cases, knee-chest positioning

– Vaginal estrogen contraindicated (pregnancy)

– Mode of delivery individualized; cesarean often chosen for severe prolapse to avoid further pelvic floor injury, but vaginal delivery is not absolutely contraindicated

– Surgery deferred until postpartum (typically ≥6 months) when tissues recover

— Mild prolapse is common in the first 6–12 months postpartum and often regresses

— Counsel: defer surgical decisions for at least 6–12 months postpartum, ideally until childbearing complete

— Initiate pelvic floor muscle training early — strong evidence for postpartum incontinence and prolapse symptom improvement

— Pessary is the mainstay until family complete

— Uterine-sparing procedures (hysteropexy) preserve fertility but recurrence data still maturing

— Avoid mesh sacrocolpopexy or hysterectomy-based repairs until childbearing complete

— Earlier onset, higher recurrence after surgery

— Counsel about lower success rates; consider mesh-augmented repair when appropriate

— Address technique (avoid Valsalva-loaded lifting), pelvic floor PT, weight optimization

Step 3 management: A 28-year-old with stage II prolapse 4 months postpartum wanting another pregnancy → pelvic floor PT + reassurance, not pessary or surgery as first move. Time and rehab cure most postpartum prolapse.

Pregnancy-associated prolapse:

Postpartum prolapse:

Younger women / desiring future fertility:

Connective tissue disorders (Ehlers-Danlos, Marfan):

Athletes and heavy lifters:

Complications and Adverse Outcomes

— Vaginal/cervical erosion and ulceration — exposed mucosa rubs against clothing; bleeding, infection, rarely malignant transformation in chronic procidentia

— Obstructive uropathy — ureteral kinking → hydronephrosis → AKI or CKD progression

— Urinary retention with overflow incontinence and recurrent UTIs

— Defecatory dysfunction — chronic constipation, splinting, fecal impaction

— Sexual dysfunction — dyspareunia, avoidance, relationship strain

— Quality of life impact: depression, social isolation, exercise avoidance

— Vaginal discharge and odor (most common, mild)

— Erosion or ulceration — pause use, vaginal estrogen, downsize

— Incarceration and fistula (vesicovaginal or rectovaginal) — rare, almost exclusively in neglected pessaries; emphasizes routine follow-up

— Bleeding — always evaluate for malignancy if persistent

— Bleeding, infection, VTE, anesthesia risks

— Ureteral injury (1–2% in uterosacral suspension, lower with intraoperative cystoscopy)

— Bladder/bowel injury during dissection

— De novo stress urinary incontinence (10–40% after prolapse repair without sling)

— De novo urgency or voiding dysfunction

— Dyspareunia especially after posterior repair with overly narrow introitus

— Recurrence — 10–30% depending on procedure and time horizon

— Mesh exposure/extrusion through vaginal mucosa (~2–10%)

— Mesh erosion into bladder or bowel — rare, requires surgical revision

— Chronic pelvic pain, dyspareunia, partner dyspareunia ("hispareunia")

— FDA ordered transvaginal mesh products off US market in 2019; abdominal sacrocolpopexy mesh remains in use

Board pearl: New-onset SUI after successful prolapse repair is so common it requires preoperative counseling and intraoperative reduction stress testing — failing to disclose this risk is a recurrent medicolegal question stem.

Untreated/advanced POP complications:

Pessary complications:

Surgical complications (general):

Mesh-specific complications (sacrocolpopexy and historical transvaginal mesh):

When to Escalate Care — Consults and Inpatient Triage

— Procidentia with vaginal ulceration, bleeding, or infection

— Inability to manually reduce prolapse

— Pessary incarceration or inability to remove

— Suspected fistula (continuous urine or stool leakage)

— Postoperative complications: mesh exposure, severe pain, suspected ureteral injury

— Obstructive AKI from procidentia → admit for prolapse reduction (Foley + pessary), urology/urogynecology consult, IV fluids, monitor electrolytes

— Acute urinary retention unrelieved by catheterization

— Sepsis from infected ulceration or pyelonephritis from obstruction

— Bowel obstruction from incarcerated enterocele (rare)

— Postoperative: hemorrhage, peritonitis, mesh-related abscess, sepsis

— Urology/urogynecology — surgical planning, complex UDS, mesh complications

— Colorectal surgery — concomitant rectal prolapse, complex posterior compartment defects, anal sphincter injury

— Physical therapy (pelvic floor specialist) — every patient benefits; do not view as a last resort

— Geriatrics — frailty assessment before major reconstruction in older adults

— Psychology/sex therapy — for sexual dysfunction and body image concerns

— Recurrent prolapse after prior repair

— Complex multicompartment defects

— Coexisting fecal incontinence or pelvic pain syndromes

— Mesh complications

— Patient preference for fellowship-trained surgeon

CCS pearl: Elderly woman with stage IV procidentia, creatinine 3.2, and bilateral hydronephrosis on US → admit, place Foley catheter, reduce prolapse with pessary or vaginal packing, IV fluids, urogynecology and urology consult, trend creatinine. Definitive surgery (often colpocleisis) is planned after renal recovery.

POP is overwhelmingly outpatient. Escalation is unusual but high-yield to recognize.

Urgent urogynecology/gynecology referral (same-week):

Emergent evaluation (ED or admission):

Multidisciplinary consults:

Specialty referral to female pelvic medicine and reconstructive surgery (FPMRS/urogynecology):

Key Differentials — Same-Category (Gynecologic/Pelvic Floor) Causes

— Anterior vaginal wall mass, classic triad: dysuria, dyspareunia, postvoid dribbling

— Tender, fluctuant; expression of pus or urine from meatus on compression

— Imaging: MRI pelvis is gold standard

— Unlike cystocele, does not reduce with Valsalva position changes

— Gartner duct cyst — anterolateral vaginal wall, mesonephric remnant, asymptomatic

— Bartholin cyst/abscess — posterolateral introitus at 4 and 8 o'clock

— Skene gland cyst — periurethral

— Vaginal wall fibroma or leiomyoma — firm, fixed, not reducible

— Vaginal cancer — fixed, ulcerated, friable, bleeding — biopsy any suspicious mass

— Cervical elongation with normal apical support — cervix protrudes but uterosacral/cardinal complex intact; differentiates on POP-Q (C protrudes, D normal)

— Cervical or endometrial polyp prolapsing through cervix

— Submucosal fibroid prolapsing through cervix ("aborting fibroid")

— Inverted uterus (postpartum or chronic with fibroid)

— Often confused with posterior vaginal prolapse but originates from anus

— Concentric rings of rectal mucosa visible at anal verge

— Frequently coexists with POP — examine perineum carefully; both may need repair

— Both bulge posteriorly; rectovaginal exam with patient straining helps distinguish — enterocele contains small bowel between rectum and vagina

— Defecography MRI is confirmatory

— Pain dominates over bulge sensation; tender levators on exam

Key distinction: A non-reducible, firm, fixed anterior vaginal mass is not a cystocele — think diverticulum, cyst, or malignancy and image with MRI before assuming prolapse.

A "vaginal bulge" or pelvic pressure is not always POP. Differentiate within the gynecologic spectrum first.

Urethral diverticulum:

Vaginal/vulvar cysts and masses:

Uterine pathology mimicking apical prolapse:

Rectal prolapse (full-thickness):

Enterocele vs high rectocele:

Levator ani avulsion or pelvic floor myofascial pain:

Key Differentials — Other-Category (Non-Gynecologic) Causes

— Overactive bladder/detrusor overactivity — urgency and frequency without anatomic prolapse

— Interstitial cystitis/bladder pain syndrome — chronic suprapubic pain relieved by voiding, pain with bladder filling; cystoscopy may show Hunner lesions

— Recurrent UTI in absence of prolapse — postmenopausal atrophy, diabetes, voiding dysfunction

— Bladder tumor — painless gross hematuria → cystoscopy

— Neurogenic bladder — MS, spinal cord injury, diabetic autonomic neuropathy → UDS

— Chronic constipation/slow-transit colon — defecatory symptoms without rectocele

— Anismus/pelvic floor dyssynergia — paradoxical contraction during defecation; needs biofeedback PT

— Hemorrhoids and anal fissure — anal pain, bleeding, but no vaginal bulge

— Inflammatory bowel disease, diverticulitis, colorectal malignancy — alarm symptoms (weight loss, bleeding, anemia)

— Rectal intussusception — defecation difficulty, identified on defecography

— Levator myalgia / pelvic floor tension myalgia — pain, not bulge; trigger points on internal exam

— Coccydynia, pudendal neuralgia — neuropathic pain, often positional

— Lumbar radiculopathy — referred pelvic pain with neurologic deficits

— Postmenopausal bleeding → endometrial cancer workup before any procedure

— Pelvic mass with ascites, weight loss, early satiety → ovarian cancer — TVUS, CA-125

— Abnormal Pap, friable cervix → cervical cancer

— Vaginal mass that bleeds → vaginal cancer

— Large-volume ascites raises intra-abdominal pressure and may produce pressure sensation mimicking prolapse

Board pearl: Before attributing pelvic pressure to POP, ensure age-appropriate cancer screening is current and that any postmenopausal bleeding is evaluated with endometrial biopsy. Missed endometrial cancer at the time of hysteropexy is a classic litigation case.

Pelvic pressure, urinary symptoms, and defecatory dysfunction overlap with many non-gynecologic conditions. Step 3 vignettes love these mimics.

Urologic mimics:

Gastrointestinal/colorectal mimics:

Musculoskeletal/neurologic:

Oncologic red flags (must exclude):

Ascites and pelvic congestion:

Long-Term Plan, Discharge Care, and Secondary Prevention

— Education on insertion/removal if patient self-manages

— Initiate vaginal estrogen in postmenopausal women to prevent erosion

— First follow-up 1–2 weeks for fit check, symptom relief, examination for ulceration

— Then every 3–6 months if clinician-managed; weekly home cleaning if self-managed

— Warning signs to report: bleeding, foul discharge, pain, inability to void or defecate

— Analgesia: scheduled acetaminophen + NSAIDs, short opioid course only if needed (opioid stewardship is a Step 3 priority)

— VTE prophylaxis — mechanical and pharmacologic per risk; SCDs intraoperatively, early ambulation, sometimes prophylactic enoxaparin

— Stool softeners (docusate) and PEG 3350 to avoid straining for 6 weeks

— Vaginal estrogen post-op in postmenopausal women

— Pelvic rest (no intercourse, tampons, douching) for 6 weeks

— No lifting >10 lb, no high-impact exercise for 6 weeks

— Trial of void before discharge; teach intermittent self-catheterization if PVR elevated

— Weight management — sustained 5–10% BMI reduction

— Treat chronic cough — smoking cessation, asthma/COPD optimization

— Constipation prevention — fiber, hydration, avoid straining

— Continue pelvic floor exercises lifelong

— Avoid heavy occupational lifting when possible; teach proper mechanics and breath control

— Manage estrogen deficiency with vaginal estrogen as appropriate

— Higher lifetime risk of recurrent prolapse (~10–30%)

— Annual pelvic exam; earlier evaluation for recurrent bulge symptoms

Step 3 management: Discharge bundle after prolapse surgery = analgesia plan, stool softener, vaginal estrogen, VTE prophylaxis, activity restrictions, voiding trial, and a 2- and 6-week postoperative visit. Missing the voiding trial leads to unrecognized urinary retention and ED return.

After pessary fitting (discharge home):

After surgical repair (discharge medications and plan):

Secondary prevention (lifelong):

Patients with prior repair:

Follow-Up, Monitoring, and Rehabilitation Cadence

— Initial PT evaluation, then 1–2 sessions/week for 12–16 weeks

— Reassess at 3 months — POP-Q exam, symptom scores (PFDI-20, PFIQ-7)

— If significant improvement → maintenance home program, annual follow-up

— If no improvement → escalate to pessary or surgery

— Self-managers: monthly self-exam, annual clinician visit

— Clinician-managed: every 3 months for cleaning and inspection

— At each visit: remove pessary, inspect for erosion/ulceration, replace; reassess fit if weight change, recurrent expulsion, or new symptoms

— Reapply vaginal estrogen instructions

— 2 weeks: wound check, address voiding/bowel issues, pain control

— 6 weeks: pelvic exam, advance activity, resume intercourse if healed, initiate PFMT

— 6 months: anatomic and symptomatic reassessment with POP-Q and validated questionnaires

— Annually thereafter: screen for recurrence and de novo symptoms (SUI, urgency, dyspareunia)

— POP-Q stage and leading-edge measurement

— Symptom scores (PFDI-20, PFIQ-7, PISQ-IR for sexual function)

— PVR if voiding symptoms

— Inspection for mesh exposure in sacrocolpopexy patients (annual speculum exam)

— Renal function if history of obstructive uropathy

— Reinforce weight, bowel, cough, and lifting habits

— Sexual health — proactively ask; do not wait for patient to volunteer

— Mental health screening — POP is associated with depression and anxiety; treat or refer

— Reassure that recurrence does not equal failure; many patients live well with combined therapies over time

Board pearl: Pelvic floor muscle training is appropriate at every stage — preoperatively to optimize outcomes, postoperatively to maintain results, and as standalone therapy for early-stage prolapse. Underutilizing PT is a recurring exam theme.

Conservative/PFMT pathway:

Pessary follow-up:

Postoperative cadence (standard urogynecology):

Monitoring parameters across visits:

Counseling at every visit:

Ethical, Legal, and Patient Safety Considerations

— Disclose: recurrence rates (10–30%), de novo SUI, de novo urgency, voiding dysfunction, dyspareunia, mesh exposure (if mesh used), need for future surgery

— Document discussion of alternatives — observation, lifestyle, PFMT, pessary, alternative surgical approaches

— Mesh consent is heightened post-FDA action: explicit discussion of mesh-specific risks and reasonable alternatives; many institutions require dedicated mesh consent forms

— Confirm patient understanding of permanent loss of vaginal intercourse capability with colpocleisis — this is the highest-risk consent failure in obliterative surgery

— POP is quintessentially preference-sensitive — there is rarely one "right" answer

— Decision aids and questionnaire-based goal-setting improve concordance with patient values

— Avoid surgeon bias toward the most technically interesting procedure

— Screen for intimate partner violence — sexual dysfunction and pelvic complaints raise the index of suspicion

— Elder abuse and neglect — neglected pessary, untreated procidentia in dependent older adults may signal caregiver neglect; report per state law

— Postoperative voiding trial failure → ensure patient leaves with catheter and clear follow-up plan; never discharge without confirmed bladder emptying or a teaching plan for self-catheterization

— Communicate operative findings, mesh use, and lot number to PCP and patient (mesh registry compliance)

— Medication reconciliation at discharge — particularly anticholinergic burden in older women

— Access to urogynecology specialists is uneven; rural and underinsured women face delays

— Cultural and language sensitivity around vaginal exams, pessary self-care, and sexual function discussions

— Value-based metrics: avoid unnecessary urodynamics, image only when indicated, leverage PT before surgery

Step 3 management: When an 84-year-old with mild dementia consents to colpocleisis, confirm decision-making capacity specific to that decision (understands no future intercourse) and engage her surrogate; document capacity assessment.

Informed consent for prolapse surgery (a Step 3 staple):

Shared decision-making:

Mandatory considerations and reporting:

Transitions of care (high-yield safety target):

Health systems and equity:

High-Yield Associations and Rapid-Fire Clinical Facts

Board pearl: When a vignette describes a postmenopausal multiparous woman with a "bulge" and stress incontinence — think POP plus likely occult SUI and order a reduction cough stress test.

Strongest risk factor for POP: vaginal parity (especially operative delivery).

Hysterectomy is a risk factor for vaginal vault prolapse later in life — counsel and consider apical suspension at the time of hysterectomy if any apical descent exists.

Apical support is the keystone of pelvic floor anatomy — repairing anterior or posterior wall without addressing apex predicts failure.

POP-Q stage II = leading edge within 1 cm of hymen — the threshold where symptoms typically appear.

Procidentia (stage IV) can cause bilateral hydronephrosis and AKI — image kidneys.

Sacrocolpopexy = gold standard for durability; colpocleisis = highest patient satisfaction in appropriate candidates.

Vaginal mesh for transvaginal POP repair was removed from US market by FDA in 2019; abdominal sacrocolpopexy mesh remains standard of care.

Pessary first-line for: pregnancy-associated prolapse, poor surgical candidates, women desiring future childbearing, and as a trial before surgery.

Vaginal estrogen improves pessary tolerance, postoperative healing, and recurrent UTI rates; low-dose preparations do not require progestin opposition.

Occult SUI: up to 40% develop new SUI after prolapse repair — preoperative reduction stress test is essential.

Concomitant midurethral sling at the time of prolapse repair reduces postoperative SUI but increases voiding dysfunction — shared decision required.

Cystoscopy intraoperatively confirms ureteral integrity after uterosacral suspension (highest ureteral injury risk).

Connective tissue disorders (EDS, Marfan) predispose to early-onset and recurrent prolapse.

First-line for stage I–II symptomatic POP: PFMT + lifestyle.

Postpartum prolapse often resolves over 6–12 months — defer surgical decisions.

POP-Q point C = cervix or vaginal cuff; point D = posterior fornix (absent post-hysterectomy) — discriminates true apical descent from cervical elongation.

Anterior wall is the most commonly involved compartment.

Defecography is the test of choice for complex posterior compartment / suspected enterocele.

Board Question Stem Patterns

— Answer: Reassurance and observation, lifestyle counseling, annual follow-up. NOT pessary or surgery.

— Workup: urinalysis, PVR, cough stress test with reduction.

— Discuss POP repair with concomitant anti-incontinence procedure; counsel on occult SUI.

— Manage: reduce prolapse (Foley + pessary or vaginal packing), IV fluids, urology/urogynecology consult.

— Definitive: colpocleisis after stabilization — matches goals (no intercourse) and surgical risk.

— Answer: Pelvic floor physical therapy and reassurance. Defer pessary/surgery.

— Concern: ureteral kinking/injury. Order cystoscopy with retrograde pyelogram or CT urogram, consult urology.

— Action: Remove pessary, inspect for ulceration. Treat with vaginal estrogen, pessary holiday. Biopsy any non-healing lesion to exclude malignancy.

— Discuss with oncology; alternatives include vaginal DHEA (prasterone), non-hormonal moisturizers, and (in some cases) low-dose vaginal estrogen.

— Counsel: abdominal sacrocolpopexy mesh remains standard; mesh exposure ~2–10%; transvaginal mesh kits no longer available in US.

— First step: pessary placement, pelvic rest, defer surgery to postpartum.

— Teaching point: apical support was not addressed; refer to urogynecology for sacrocolpopexy or apical suspension.

Step 3 management: When in doubt on a vignette, ask "Has apical support been addressed? Has occult SUI been assessed? Have lifestyle and PFMT been offered?" — the right answer usually clarifies.

Stem 1 — Asymptomatic stage II finding on routine exam:

Stem 2 — Multiparous postmenopausal woman with bulge, stress incontinence with cough:

Stem 3 — 82-year-old with procidentia, creatinine 2.8, hydronephrosis on US:

Stem 4 — 28-year-old G3P3 four months postpartum with mild bulge wanting another child:

Stem 5 — Postoperative day 1 after vaginal hysterectomy with uterosacral suspension, unable to void, flank pain:

Stem 6 — Pessary user with vaginal bleeding and discharge at 6-month follow-up:

Stem 7 — Breast cancer survivor with vaginal atrophy and pessary discomfort:

Stem 8 — Patient considering sacrocolpopexy asks about mesh:

Stem 9 — Pregnancy with second-trimester uterine prolapse:

Stem 10 — Recurrent prolapse 3 years after anterior colporrhaphy without apical suspension:

One-Line Recap

— Diagnose clinically: POP-Q with split speculum, Valsalva in lithotomy and standing; image only for hydronephrosis, complex anatomy, or malignancy concerns. Always check PVR, urinalysis, and a reduction cough stress test before surgery.

— Treat symptoms, not stage: asymptomatic prolapse → reassurance. Symptomatic → PFMT and lifestyle first, then pessary (works at any stage, any age, including pregnancy), then surgery. Match invasiveness to goals and physiologic reserve.

— Apical support is the keystone: failing to address the apex during anterior/posterior repair is the leading cause of recurrence; sacrocolpopexy is the durability gold standard, colpocleisis offers the highest satisfaction in non-sexually active older women.

— Anticipate the complications: up to 40% develop de novo SUI after repair; procidentia can cause AKI from hydronephrosis; pessaries need scheduled care plus vaginal estrogen; mesh complications require informed consent and long-term surveillance.

Board pearl: If you remember only three things — (1) offer pelvic floor PT and a pessary before any surgery, (2) always do a reduction stress test to detect occult SUI, and (3) advanced prolapse with rising creatinine = image the kidneys — you will answer the majority of Step 3 POP vignettes correctly.

Pelvic organ prolapse is a clinical, preference-sensitive condition diagnosed by exam (POP-Q) in a parous, often postmenopausal woman with a vaginal bulge, managed by a stepwise pathway — lifestyle and pelvic floor muscle training, then pessary, then surgery tailored to anatomy and goals — with vigilant attention to apical support, occult stress incontinence, and procidentia-associated obstructive uropathy.

High-yield recap bullets: